Skip to main content

Delaying second Pfizer COVID shot boosts immune response in over-80s, study finds

Extending the gap between doses of the Pfizer–BioNTech COVID-19 vaccine from three to 12 weeks significantly boosts the antibody response in elderly people, according to a new U.K. study.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.